Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

about

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

Item

http://www.wikidata.org/entity/Q47548529

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

@en

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

@nl

type

Item

label

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

@en

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

@nl

prefLabel

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

@en

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

@nl

P1476

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.

@en

P2093

Helen Lew

http://www.w3.org/2001/XMLSchema#string

Sangrye Park

http://www.w3.org/2001/XMLSchema#string

Seunghyun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome

Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm

Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.

Safety and efficacy of botulinum toxin type A following long-term use.

Botulinum toxin in ophthalmology.

Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: a new botulinum neurotoxin A.

Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.

Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3341/KJO.2017.0030

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29376224

http://www.w3.org/2001/XMLSchema#string

P932

5801084

http://www.w3.org/2001/XMLSchema#string